Thought Leadership
How Life Sciences Companies Can Detect Adverse Events on Social Media
An overview of the evolving role of social media in pharmacovigilance (PV) for pharmaceutical companies, highlighting how social media platforms have become crucial sources for adverse event reporting and post-marketing safety information, and outlining the challenges and...
ISPOR Europe 2020 Virtual Poster - Usability Testing for eCOAs
In order to ensure a fluid experience for a patient, usability testing is a critical data point to consider. Addressing both a patient’s needs and access to a digital platform is key to data collection. TransPerfect, along with our partners from Parexel, Clinical Ink, and...
The Paper Chase - Clinical Outcome Assessments in the Digital Age
Patients are, at last, gaining a voice in healthcare. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications that should influence policy and treatment decisions. The U.S. Food & Drug...
Swimming in a Data Lake of eCOA Wearables
We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest whitepaper , Mark Wade, Global Practice Leader for TransPerfect Life Sciences examines the considerations of adopting these sensors as an addition...
Wearables for eCOA: Practical Considerations for Improving Patient Data Capture
This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization,...